170 related articles for article (PubMed ID: 34769070)
1. Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
Todoerti K; Gallo Cantafio ME; Oliverio M; Juli G; Rocca C; Citraro R; Tassone P; Procopio A; De Sarro G; Neri A; Viglietto G; Amodio N
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769070
[TBL] [Abstract][Full Text] [Related]
2. Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
Katodritou E; Terpos E; North J; Kottaridis P; Verrou E; Gastari V; Chadjiaggelidou C; Sivakumaran S; Jide-Banwo S; Tsirogianni M; Kapetanos D; Zervas K; Lowdell MW
Am J Hematol; 2011 Dec; 86(12):967-73. PubMed ID: 21919039
[TBL] [Abstract][Full Text] [Related]
3. Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
Murugesan A; Lassalle-Claux G; Hogan L; Vaillancourt E; Selka A; Luiker K; Kim MJ; Touaibia M; Reiman T
J Nat Prod; 2020 Dec; 83(12):3526-3535. PubMed ID: 33210536
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Jakubikova J; Cervi D; Ooi M; Kim K; Nahar S; Klippel S; Cholujova D; Leiba M; Daley JF; Delmore J; Negri J; Blotta S; McMillin DW; Hideshima T; Richardson PG; Sedlak J; Anderson KC; Mitsiades CS
Haematologica; 2011 Aug; 96(8):1170-9. PubMed ID: 21712538
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Anti-Cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the HT-29 Colorectal Cancer Cell Line.
Sani NS; Onsori H; Akrami S; Rahmati M
Anticancer Agents Med Chem; 2022; 22(2):390-394. PubMed ID: 33687886
[TBL] [Abstract][Full Text] [Related]
6. Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma.
Gordon S; Helfrich MH; Sati HI; Greaves M; Ralston SH; Culligan DJ; Soutar RL; Rogers MJ
Br J Haematol; 2002 Nov; 119(2):475-83. PubMed ID: 12406088
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.
Brito C; Tomás A; Silva S; Bronze MR; Serra AT; Pojo M
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430068
[TBL] [Abstract][Full Text] [Related]
8. Hydroxytyrosol: A natural compound with promising pharmacological activities.
Bertelli M; Kiani AK; Paolacci S; Manara E; Kurti D; Dhuli K; Bushati V; Miertus J; Pangallo D; Baglivo M; Beccari T; Michelini S
J Biotechnol; 2020 Feb; 309():29-33. PubMed ID: 31884046
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective Effects of the Polyphenol Hydroxytyrosol from Olive Oil.
Tejada S; Pinya S; Del Mar Bibiloni M; Tur JA; Pons A; Sureda A
Curr Drug Targets; 2017; 18(13):1477-1486. PubMed ID: 27719659
[TBL] [Abstract][Full Text] [Related]
10. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.
Lam C; Ferguson ID; Mariano MC; Lin YT; Murnane M; Liu H; Smith GA; Wong SW; Taunton J; Liu JO; Mitsiades CS; Hann BC; Aftab BT; Wiita AP
Haematologica; 2018 Jul; 103(7):1218-1228. PubMed ID: 29622655
[TBL] [Abstract][Full Text] [Related]
11. The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in
Díaz T; Rodríguez V; Lozano E; Mena MP; Calderón M; Rosiñol L; Martínez A; Tovar N; Pérez-Galán P; Bladé J; Roué G; de Larrea CF
Haematologica; 2017 Oct; 102(10):1776-1784. PubMed ID: 28751557
[TBL] [Abstract][Full Text] [Related]
12. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
Blotta S; Jakubikova J; Calimeri T; Roccaro AM; Amodio N; Azab AK; Foresta U; Mitsiades CS; Rossi M; Todoerti K; Molica S; Morabito F; Neri A; Tagliaferri P; Tassone P; Anderson KC; Munshi NC
Blood; 2012 Dec; 120(25):5002-13. PubMed ID: 22821765
[TBL] [Abstract][Full Text] [Related]
13. Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells.
Luo C; Li Y; Wang H; Cui Y; Feng Z; Li H; Li Y; Wang Y; Wurtz K; Weber P; Long J; Liu J
Curr Cancer Drug Targets; 2013 Jul; 13(6):625-39. PubMed ID: 23597197
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myeloma.
Blatt K; Herrmann H; Stefanzl G; Sperr WR; Valent P
Oncotarget; 2016 Oct; 7(40):65627-65642. PubMed ID: 27582537
[TBL] [Abstract][Full Text] [Related]
15. Oleocanthal inhibits proliferation and MIP-1α expression in human multiple myeloma cells.
Scotece M; Gómez R; Conde J; Lopez V; Gómez-Reino JJ; Lago F; Smith AB; Gualillo O
Curr Med Chem; 2013; 20(19):2467-75. PubMed ID: 23521677
[TBL] [Abstract][Full Text] [Related]
16. Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells.
Stefka AT; Park JH; Matsuo Y; Chung S; Nakamura Y; Jakubowiak AJ; Rosebeck S
Blood Cancer J; 2016 Aug; 6(8):e460. PubMed ID: 27540718
[No Abstract] [Full Text] [Related]
17. Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health.
Karković Marković A; Torić J; Barbarić M; Jakobušić Brala C
Molecules; 2019 May; 24(10):. PubMed ID: 31137753
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo.
Bono C; Karlin L; Harel S; Mouly E; Labaume S; Galicier L; Apcher S; Sauvageon H; Fermand JP; Bories JC; Arnulf B
Haematologica; 2012 Jul; 97(7):1101-9. PubMed ID: 22271897
[TBL] [Abstract][Full Text] [Related]
19. Hydroxytyrosol-Derived Compounds: A Basis for the Creation of New Pharmacological Agents for Cancer Prevention and Therapy.
Bernini R; Gilardini Montani MS; Merendino N; Romani A; Velotti F
J Med Chem; 2015 Dec; 58(23):9089-107. PubMed ID: 26225717
[TBL] [Abstract][Full Text] [Related]
20. Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma.
Bordini J; Galvan S; Ponzoni M; Bertilaccio MT; Chesi M; Bergsagel PL; Camaschella C; Campanella A
Leukemia; 2017 Apr; 31(4):967-970. PubMed ID: 27881873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
